The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
The opening session will take a high-level look ahead at global pharmaceutical manufacturing and related regulatory systems. We will discuss how COVID has impacted our business and the applications of future manufacturing operations and the facilities required to adequately produce product that is safe, cost effective and meets the needs of the patients we serve. Key industry leaders will share their perspectives and their insights into how they see the industry changing as we move forward from COVID.
Dr. Matthew
Hepburn,
M.D.,
Senior Advisor To the OSTP Director on Pandemic Prevention,
U.S. Office of Science and Technology Policy, Executive Office of the President
You must be logged in and own this session in order to
post comments.